Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daisylyn Senna Tan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|August 17, 2019
SOX17 in cellular reprogramming and cancerDaisylyn Senna Tan, Markus Holzner, Mingxi Weng, et al.
Nucleic Acids Research|August 22, 2023
Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17Haoqing Hu, Derek Hoi Hang Ho, Daisylyn Senna Tan, et al.
The FEBS Journal|October 1, 2019
Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17Yogesh Srivastava, Daisylyn Senna Tan, Vikas Malik, et al.
Nucleic Acids Research|January 12, 2023
The homeodomain of Oct4 is a dimeric binder of methylated CpG elementsDaisylyn Senna Tan, Shun Lai Cheung, Ya Gao, et al.
Nucleic Acids Research|September 21, 2022
OCT4 interprets and enhances nucleosome flexibilityCaitlin M MacCarthy, Jan Huertas, Claudia Ortmeier, et al.
Nature Communications|November 14, 2024
The emergence of Sox and POU transcription factors predates the origins of animal stem cellsYa Gao, Daisylyn Senna Tan, Mathias Girbig, et al.
Science Advances|August 23, 2023
An engineered Sox17 induces somatic to neural stem cell fate transitions independently from pluripotency reprogrammingMingxi Weng, Haoqing Hu, Matthew S Graus, et al.
Molecular Biology and Evolution|March 15, 2021
Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate EngineeringDaisylyn Senna Tan, Yanpu Chen, Ya Gao, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2019
Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndromeKen McElreavey, Anne Jorgensen, Caroline Eozenou, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|August 17, 2019
SOX17 in cellular reprogramming and cancerDaisylyn Senna Tan, Markus Holzner, Mingxi Weng, et al.
Nucleic Acids Research|August 22, 2023
Evaluation of the determinants for improved pluripotency induction and maintenance by engineered SOX17Haoqing Hu, Derek Hoi Hang Ho, Daisylyn Senna Tan, et al.
The FEBS Journal|October 1, 2019
Cancer-associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17Yogesh Srivastava, Daisylyn Senna Tan, Vikas Malik, et al.
Nucleic Acids Research|January 12, 2023
The homeodomain of Oct4 is a dimeric binder of methylated CpG elementsDaisylyn Senna Tan, Shun Lai Cheung, Ya Gao, et al.
Nucleic Acids Research|September 21, 2022
OCT4 interprets and enhances nucleosome flexibilityCaitlin M MacCarthy, Jan Huertas, Claudia Ortmeier, et al.
Nature Communications|November 14, 2024
The emergence of Sox and POU transcription factors predates the origins of animal stem cellsYa Gao, Daisylyn Senna Tan, Mathias Girbig, et al.
Science Advances|August 23, 2023
An engineered Sox17 induces somatic to neural stem cell fate transitions independently from pluripotency reprogrammingMingxi Weng, Haoqing Hu, Matthew S Graus, et al.
Molecular Biology and Evolution|March 15, 2021
Directed Evolution of an Enhanced POU Reprogramming Factor for Cell Fate EngineeringDaisylyn Senna Tan, Yanpu Chen, Ya Gao, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|July 25, 2019
Pathogenic variants in the DEAH-box RNA helicase DHX37 are a frequent cause of 46,XY gonadal dysgenesis and 46,XY testicular regression syndromeKen McElreavey, Anne Jorgensen, Caroline Eozenou, et al.
Pageof 1